KMID : 0861120090130020051
|
|
Korean Journal of Oriental Preventive Medicine 2009 Volume.13 No. 2 p.51 ~ p.64
|
|
The Anticancer Effects and Drug Metabolic Enzyme Change by Oral Intake of Agrimonia Pilosa Ledeb
|
|
Rhee See-Hyung
Jung Hee Go Ho-Yeon Choi You-Kyung Park Jong-Hyung Kim Ji-Hye Ko Seong-Gyu Jeon Chan-Yong
|
|
Abstract
|
|
|
Objective:This research aimed was to investigate the anti-tumor effect, safety, mechanism and metabolizing enzyme of Agrimonia pilosa LEDEB(APL) in female C57B/L mouse.
Methods:At first, to evaluate the anti-tumor activity of APL, we divided into four groups, normal, control, APL100(100§·/§¸), APL150(150§·/§¸). LLC obtained American Type Culture Collection was used. LLC had been inoculated to induce tumor. To measure the anti-tumor effect of APL, we calibrate tumor size and weight. To study for mechanism of anti-tumor in APL, we used western blotting and to know metabolizing enzyme in APL we used to real-time PCR.
Results:APL100, APL150 inhibited tumor growth after medicine injected. APL did not only induced caspase-dependent apoptosis in LLC-bearing mouse tumor. In APL100, it were decreased 72% in CYP3A11. In APL150, it were decreased 62%, 75% in CYP3A11 and MRP1a respectively.
Conclusion:These results suggests that APL has some anti-tumor effects in female C57B/L mouse tumor. APL should be careful use with other drugs related with CYP3A11 or MRP1a.
|
|
KEYWORD
|
|
Agrimonia pilosa LEDEB(APL), Antitumor, CYP3A11, Metabolizing Enzyme
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|